Literature DB >> 7889951

In vitro activity of biapenem against beta-lactamase producing Enterobacteriaceae.

R Alonso1, A Fernández-Aranguiz, K Colom, A Morla, E Suinaga, A Umaran, R Cisterna.   

Abstract

The activity of biapenem was compared with that of imipenem and cefotaxime against 108 strains of beta-lactamase producing Enterobacteriaceae. Biapenem and imipenem were very active, inhibiting 90% of the strains at a concentration of 0.5 microgram/ml. Both carbapenems were very active against plasmidic beta-lactamase producers, with MIC90s below 1 microgram/ml. However, the MIC90 of biapenem for cephalosporinase producers was 1 microgram/ml. Against strains producing extended-spectrum beta-lactamases, biapenem exhibited better activity against TEM-type producers (MIC90 0.25 microgram/ml) than against SHV-type producers (MIC90 0.5 microgram/ml). Overall, the in vitro antibacterial activity of biapenem is similar to that of imipenem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889951     DOI: 10.1007/bf02111342

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

1.  In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.

Authors:  M Yoshida; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.

Authors:  P J Petersen; N V Jacobus; W J Weiss; R T Testa
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

5.  In vitro activity and beta-lactamase stability of LJC 10,627.

Authors:  H C Neu; J W Gu; W Fang; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

6.  In vitro activity of L-627, a new carbapenem.

Authors:  C R Catchpole; R Wise; D Thornber; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

  6 in total
  2 in total

1.  A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects.

Authors:  David C Griffith; Elizabeth E Morgan; Michael N Dudley; Jeffery S Loutit
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

Review 2.  Biapenem.

Authors:  Caroline M Perry; Tim Ibbotson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.